EUVIMEDEUVIMED entdecken
Crossref

The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma

Advaitaa Ravipati, Tejus Pradeep, Philippe Jean-Pierre, Keyvan Nouri

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.8368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Advaitaa Ravipati und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansMaleFemaleMiddle AgedAgedUnited StatesUnited States Food and Drug AdministrationIpilimumabImidazolesAdultAdverse Drug Reaction Reporting SystemsOximesNivolumabVemurafenibAged, 80 and overSex FactorsImmune Checkpoint Inhibitors

Substanzen

IpilimumabImidazolesOximesNivolumabVemurafenibdabrafenibImmune Checkpoint Inhibitors

Zitieren

APA

Ravipati, A., Pradeep, T., Jean-Pierre, P., & Nouri, K. (2025). The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8368

Vancouver

Ravipati A, Pradeep T, Jean-Pierre P, Nouri K. The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8368

BibTeX
@article{Ravipati2025,
  author = {Ravipati, Advaitaa and Pradeep, Tejus and Jean-Pierre, Philippe and Nouri, Keyvan},
  title = {The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.8368}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche